Nicox and pSivida enter collaboration agreement to develop sustained release drug for glaucoma patients​

2 weeks ago DieselGasoil Comments Off on Nicox and pSivida enter collaboration agreement to develop sustained release drug for glaucoma patients​

Oct 10 (Reuters) – Nicox SA

* Nicox-Co and pSivida enter strategic collaboration agreement to develop sustained release drug to lower intraocular pressure in patients with glaucoma​

* Would make additional payments for any incremental development activities for each implant formulation product candidate

* Expected payments from Nicox associated with agreement are not considered material to Nicox’s financial statements at this time​

* Says ‍pSivida will be responsible for initial development activities of ocular insert formulations, for which it will receive undisclosed sums​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.